Despina Yancopoulou

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “C3-targeted therapy in periodontal disease: moving closer to the clinic”.

C3-targeted therapy in periodontal disease: moving closer to the clinic

Trends in Immunology(2021)10.1016/j.it.2021.08.001

N/A

1.2DataRank · unranked

46 citations

Hatice Hastürk, John D. Lambris, Danae A. Apatzidou, Georgios N. Belibasakis, Nagihan Bostancı +28 more

The first case of COVID-19 treated with the complement C3 inhibitor AMY-101

Clinical Immunology(2020)10.1016/j.clim.2020.108450

N/A

0DataRank · unranked

297 citations

Annalisa Ruggeri, Antonio M. Risitano, Piera Angelillo, Despina Yancopoulou, Dimitrios C. Mastellos +7 more

Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy

Clinical Immunology(2020)10.1016/j.clim.2020.108598

N/A

0DataRank · unranked

265 citations

Bruno G. P. Pires da Silva, Benedito Antônio Lopes da Fonseca, Natasha Peixoto Fonseca, Maria Auxiliadora‐Martins, Sara Mastaglio +18 more

Prolonged intraocular residence and retinal tissue distribution of a fourth-generation compstatin-based C3 inhibitor in non-human primates

Clinical Immunology(2020)10.1016/j.clim.2020.108391

N/A

0DataRank · unranked

22 citations

Justin T. Gumas, Rebecca Lee, Merita Rumano, Nadja Berger, Avneesh Gautam +13 more